This product image provided by Aprecia Pharmaceuticals shows Spritam 750 mg, foreground, and 1000 mg tablets.
AP
By Tanya Basu
August 4, 2015
TIME Health
For more, visit TIME Health.

The Food and Drug Administration has approved the first 3D printed pill.

The medicine, Spritam (levetiracetam), helps to treat epilepsy. Previous levetiracetam tablets did not dissolve easily, but the new version boasts porous layers that make it easily dissolvable, according to a press release from the company, Aprecia Pharmaceuticals. A spokesperson for the FDA confirmed to the Associated Press that Spritam is the first 3D printed prescription tablet to gain approval.

Seizure medication is often too large and difficult to swallow—particularly for the elderly and children—making advances in 3D printing key for epileptics and other who suffer from seizures, according to the company.

“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” said Don Wetherhold, Chief Executive Officer of Aprecia.

The pill would be the latest in a series of healthcare products that utilize 3D printing, including jaw replicas, dental implants, and hip replacements. Scientists are currently working to develop 3D printed tracheas and bones, ears, kidneys, and skin.

SPONSORED FINANCIAL CONTENT

You May Like

EDIT POST